Rubinstein

Conte, E. D. Barry, E. E. Rubinstein, H. Determination of Caffeine in Beverages by Capillary Zone Electrophoresis, ... 

I. Rubinstein, E. Sabatani, R. Maoz, andj. Sagiv, Electroanal Chem. 219, 365 (1987). 

Monographs bv Sastiw (1988), Finch and Dobbv (1990), and Rubinstein (1994) provide an oveniew of the design and operational aspects of Rotation columns,... 

Hartgraves, G A, Burton, D J 3rd Chemical Congress of North America Toronto, Canada, June 1988, Abstract FLUO 30 Nguyen, T, Rubinstein, M, Wakselman,C 7 Org Chem 1981,46 1938 Hudlicky, M J Fluorine Chem 1981,18 383 Coe, P L, Milner, N E 7 Fluorine Chem 1972/73, 2, 167 Fuchikami, T, Ojima, 1 7 Fluorine Chem 1983,22, 541 Chen, Q, Chen, Y, Huang, W Huaxue Xuebao 1984, 42 906, Chem Abstr 1985,102, 5317t... 

Fawcett, and the structure of the mercury-ethanol interface, 59 Feldberg and Rubinstein, theory of electrochemical polymerization, 560 Film... 

I. Rubinstein, ed., Physical Electrochemistry. Principles, Methods, and Applications, Marcel Dekker, Inc., New York (1995). 

Trihexyphenidyl (Artane) and benztropine (Cogentin) are prescription drugs used in the treatment both of Parkinson s disease and the extrapyramidal side effects produced by neuroleptic medication. They are occasionally abused for their mind-altering properties, which occur at toxic doses (Perry et al. 1978). Abusers often try to obtain these drugs by false representation of extrapyramidal symptoms, which are claimed to result from the use of phenothi-azines or other neuroleptics (Rubinstein 1978). 

Ricaurte GA, McCann UD, Szabo Z, et al Toxicodynamics and long-term toxicity of the recreational drug 3,4-methylenedioxy-methamphetamine (MDMA, Ecstasy ). Toxicol Lett 112-113 143-146, 2000 Robinson TN, Killen JD, Taylor CB, et al Perspectives on adolescent substance use a defined population study. JAMA 258 2072-2076, 1987 Rubinstein JS Abuse of antiparkinson drugs feigning of extrapyramidal symptoms to obtain trihexyphenidyl. JAMA 239 2365, 1978 Rumack BH (ed) LSD, in Poisindex, Vol 54. Denver, CO, Micromedex, 1987 Rusyniak DE, Banks ML, Mills EM, et al Dantrolene use in 3,4-methylenedioxymethamphetamine ( ecstasy )-medicated hyperthermia (letter). Anesthesiology 10 263, 2004... 

Ribeiro, A. J., Neufeld, R. Arnaud, P. Chaumeil, J. C. (1999). Microencapsulation of lipophilic drugs in chitosan-coated alginate microspheres. International Journal of Pharmaceutics, Vol. 187,1, (September 1999), pp. (115-123), ISSN 0378-5173 Rubinstein, A. (1995). Approaches and opportunities in colon-specific drug-delivery. Critical Reviews in Therapeutic Drug Carrier Systems, Vol 12, 2-3,1995), pp. (101-149), ISSN 0743-4863... 

---